ATE209487T1 - Verfahren zur behandlung von krebs mittels strukturierten lipiden - Google Patents

Verfahren zur behandlung von krebs mittels strukturierten lipiden

Info

Publication number
ATE209487T1
ATE209487T1 AT91904991T AT91904991T ATE209487T1 AT E209487 T1 ATE209487 T1 AT E209487T1 AT 91904991 T AT91904991 T AT 91904991T AT 91904991 T AT91904991 T AT 91904991T AT E209487 T1 ATE209487 T1 AT E209487T1
Authority
AT
Austria
Prior art keywords
treating cancer
structured lipids
fatty acids
therapy
structured
Prior art date
Application number
AT91904991T
Other languages
English (en)
Inventor
Bruce R Bistrian
Original Assignee
New England Deaconess Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New England Deaconess Hospital filed Critical New England Deaconess Hospital
Application granted granted Critical
Publication of ATE209487T1 publication Critical patent/ATE209487T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT91904991T 1990-01-25 1991-01-23 Verfahren zur behandlung von krebs mittels strukturierten lipiden ATE209487T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/470,164 US5081105A (en) 1988-01-15 1990-01-25 Method of treating cancer using structured lipids
PCT/US1991/000462 WO1991011180A1 (en) 1990-01-25 1991-01-23 Method of treating cancer using structured lipids

Publications (1)

Publication Number Publication Date
ATE209487T1 true ATE209487T1 (de) 2001-12-15

Family

ID=23866529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904991T ATE209487T1 (de) 1990-01-25 1991-01-23 Verfahren zur behandlung von krebs mittels strukturierten lipiden

Country Status (8)

Country Link
US (1) US5081105A (de)
EP (1) EP0512076B1 (de)
JP (1) JPH05506644A (de)
AT (1) ATE209487T1 (de)
AU (1) AU638113B2 (de)
CA (1) CA2074492A1 (de)
DE (1) DE69132833D1 (de)
WO (1) WO1991011180A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021939A1 (en) * 1992-04-27 1993-11-11 New England Deaconess Hospital Corporation Method of treating cancer
US5571553A (en) * 1992-09-18 1996-11-05 University Of Medicine And Dentistry Of New Jersey High energy food products containing partially hydrogenated structured lipids
CA2151820C (en) * 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
US5814204A (en) * 1996-10-11 1998-09-29 Corpex Technologies, Inc. Electrolytic decontamination processes
US6013665A (en) * 1997-12-16 2000-01-11 Abbott Laboratories Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
US5817695A (en) * 1997-12-24 1998-10-06 Pellico; Michael A. Nutritional product with high fat, low carbohydrate and amino acid imbalance
US6291496B1 (en) 1999-12-27 2001-09-18 Andrew J. Dannenberg Treating cancers associated with overexpression of class I family of receptor tyrosine kinases
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US6864242B2 (en) * 2001-03-05 2005-03-08 Stephen P. Ernest Enteral formulation
US7041840B2 (en) * 2002-12-18 2006-05-09 Alberta Research Council Inc. Antioxidant triacylglycerols and lipid compositions
EP1723096A4 (de) * 2004-03-04 2008-03-05 Htl High Tech Lipids Ltd Strukturierte triglyceride und emulsionen, die diese enthalten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
US4607052A (en) * 1983-04-15 1986-08-19 Roussel-Uclaf Triglycerides, dietetic and therapeutical applications and compositions containing them
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
US4906664A (en) * 1988-01-15 1990-03-06 New England Deaconess Hospital Corporation Nutritional supplement for treatment of cancer cachexia

Also Published As

Publication number Publication date
AU638113B2 (en) 1993-06-17
DE69132833D1 (de) 2002-01-10
WO1991011180A1 (en) 1991-08-08
AU7338591A (en) 1991-08-21
EP0512076A4 (en) 1993-03-03
EP0512076A1 (de) 1992-11-11
US5081105A (en) 1992-01-14
CA2074492A1 (en) 1991-07-26
JPH05506644A (ja) 1993-09-30
EP0512076B1 (de) 2001-11-28

Similar Documents

Publication Publication Date Title
DE69132833D1 (de) Verfahren zur behandlung von krebs mittels strukturierten lipiden
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
ATE106867T1 (de) 13-trans-retinsäureester.
IT8720700A0 (it) Procedimento per l'estrazione di esteri di acidi grassi poliinsaturi da olii di pesce e composizioni farmaceutiche e// dietetiche contenenti detti esteri.
ZA914936B (en) Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
DK0764405T3 (da) Ernæringspræparat
DK0404058T3 (da) Fedtstofblanding, fremgangsmåde til fremstilling deraf samt anvendelse deraf
ES2063194T3 (es) Procedimiento de produccion de acido fosfatidico.
ATE128352T1 (de) Diät zur besserem ueberleben von kranken mit sepsis.
ATE45091T1 (de) Pharmazeutische zubereitung mit speziellen 1,2diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich.
NL980014I2 (nl) Lipiden bevattende emulsie bedoeld voor parenterale of enterale toediening.
ATE114462T1 (de) Strukturiertes lipid enthaltend milchfett.
DE3878812D1 (de) Omega-3-fettsaeuren zur behandlung von traumatischen verwundungen.
DE3684904D1 (de) Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
NO303526B1 (no) FremgangsmÕte for fremstilling av et farmas°ytisk preparat inneholdende probukol med forh°yet biotilgjengelighet
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DE69205562D1 (de) Dicarbonsäure-derivate von 6-12 kohlenstoffatomen sowie anwendung dieser derivate sowie der freien dicarbonsäuren zur herstellung von arzneimitteln zur enteralen und parenteralen ernährung.
BE883698A (fr) Procede de preparation d'acides aliphatiques insatures et de leurs esters et catalyseurs utilises
SE8304332L (sv) Lekemedel med cytostatisk verkan
DE3784738D1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
SE8800101D0 (sv) Anvendning av essentiella fettsyror for framstellning av ett preparat for behandling av eksem
IS3562A7 (is) Aðferð til að efnabæta fitu með tilliti til fjölómettaðra fitusýra og fosfatíða
IT1261959B (it) Composizione farmaceutica atta a migliorare la biodisponibilita' dell'acido eicosapentaenoico e decosaesaenoico
HU900883D0 (en) Process for preparation of n-acyl-sarcosine and salts thereof /salts of sarcoside of fatty acids/
NO174346C (no) Fremgangsmåte for fremstilling av 5-aroyl-1,2-dihydro-3H-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer og alkylestere og salter derav

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties